Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-01-15
著者
-
Sao Hiroshi
Department of Hematology, Meitetsu Hospital
-
MURAYAMA Tohru
Department of Hematology, Hyogo Medical Center for Adults
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
KODERA Yoshihisa
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
MATSUO Keitaro
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
Kami Masahiro
Division Of Exploratory Research Institute Of Medical Science University Of Tokyo
-
Kami Masahiro
Jr東京総合病院 血液内科
-
NISHIDA Tetsuya
Department of Internal Medicine, Japanese Red Cross Nagoya First Hospital
-
HIRAI Hisamaru
Department of Hematology and Oncology, Graduate School of Medicine
-
OKAMOTO Shinichiro
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
HARA Masamichi
Division of Hematology, Ehime Prefectural Central Hospital
-
KANAMORI Heiwa
Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of
-
ATSUTA Yoshiko
Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University
-
Harada Mine
Department Of Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Harada M
Department Of Hematology-oncology Ehime Prefectural Central Hospital
-
Harada Mine
岡山大学 第2内科
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Matsue Kosei
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Matsuo Keitaro
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Matsuo Keitaro
国立がんセンター中央病院 造血幹細胞移植グループ
-
Matsuo Keitaro
虎の門病院(共済)
-
Kobayashi Y
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
Kagami Yoshitoyo
東京大学医科学研究所ヒトゲノム解析センター
-
Saito H
Department Of Hematology Meitetsu Hospital
-
Sakamaki Hisashi
琉球大学 医学部血液免疫検査学分野
-
Sakamaki Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Hiraoka Sakamaki
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Okamoto S
Division Of Hematology Department Of Medicine Keio University School Of Medicine
-
Okamoto Shinichiro
慶応義塾大学 医学部内科学血液研究室
-
Okamoto Shin-ichiro
国立がんセンター中央病院 血液内科
-
Yamamoto Kazuhito
愛知県がんセンター中央病院 血液･細胞療法部
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Hamaguchi M
Nagoya National Hospital Nagoya
-
Hamaguchi Motohiro
Department Of Hematology Clinical And Research Center National Hospital Organization Nagoya Medical
-
Atsuta Yoshiko
Department Of Hsct Data Management Nagoya University School Of Medicine
-
Nishida Tetsuya
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
Sao Hiroshi
Department Of Hematology Hamamatsu Medical Center
-
Hirai Hisamaru
Department Of Hematology And Oncology Graduate School Of Medicine
-
Harada Mine
九州大学 医学研究院病態修復内科学
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Saito H
Nagoya Central Hospital
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Soda Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Soda Hisashi
Department Of Internal Medicine Isahaya Insurance General Hospital
-
Suzuki Hisamitsu
国立療養所中部病院長寿医療研究センター
-
Murayama Tohru
Department Of Hematology Hyogo Cancer Center
-
MATSOU Keitaro
Second Department of Internal Medicine Okayama University Medical School
-
Kawakami M
Department Of Hematology Nagoya Daini Red Cross Hospital
-
Kami Masahiro
Department Of Internal Medicine Toranomon Hospital
-
Kanamori Heiwa
Department Of Hematology Kanagawa Cancer Center
-
Kanamori Heiwa
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Kobayashi Yukio
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Okamoto Shin-ichiro
Division Of Hematology Department Of Medicine Keio University School Of Medicine
-
MITSUI Yoko
Department of Surgery
-
Matsuo Keitaro
Division Of Epidemiology And Prevention Aichi Cancer Center
-
Hara M
Department Of Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Science
-
Harada Mine
Department Of Internal Medicine Ii Okayama University Graduate School Of Medicine And Dentistry
-
Harada M
Chiba Univ. Chiba Jpn
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Murai Yoshiro
Department Of Hematology Tama Hokubu Medical Center
-
Hirai Hisamaru
Department Of Hematology And Oncology Faculty Of Medicine University Of Tokyo
-
Hirai Hisamaru
Department Of Cell Therapy And Transplantation University Of Tokyo
-
Nishida Tetsuya
Department Of Bioengineering Nagaoka University Of Technology
-
Okamoto Shin-ichiro
Department Of Medicine Keio University School Of Medicine
-
Hidaka Michihiro
Department Of Internal Medicine Kumamoto Medical Center National Hospital Organization
-
Saito H
Nagoya National Hospital
-
Saito H
Nagoya National Hospital Nagoya Jpn
-
Atsuta Yoshiko
Department Of Hsct Data Management And Biostatistics Nagoya University School Of Medicine
-
Hara Masamichi
Division Of Hematology Ehime Prefectural Central Hospital
-
Kodera Y
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
Kodera Yoshihisa
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Sakamaki Hisashi
Tokyo Metropolitan Komagome Hospital Tokyo Jpn
-
Sakamaki H
Tokyo Metropolitan Komagome Hospital Tokyo Jpn
-
Harada Mine
Second Department Of Internal Medicine Okayama University School Of Medicine
-
Okamoto Shinichiro
Division Of Hematology Department Of Internal Medicane Keio University School Of Medicine
-
Okamoto Shinichiro
Division Of Hematology/infectious Disease/rheumatology School Of Medicine Keio University
-
Okamoto Shinichiro
Department Of Hematology Keio University School Of Medicine
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Kawakami Manabu
Department Of Cancer Immunotherapy Osaka University Graduate School Of Medicine
-
Matsumoto Yosuke
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Moriuchi Yukiyoshi
Nagasaki Cml Study Group Nagasaki Jpn
-
Miyazaki Yoshitsugu
Second Department Of Internal Medicine Nagasaki University Graduate School Of Biomedical Science
-
Saito Hidehiko
Nagoya Central Hospital Nagoya Jpn
-
Hara Masamichi
Department Of Internal Medicine Kumamoto Medical Center National Hospital Organization
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Komiyam Y
Akita Univ. School Of Medicine Akita Jpn
-
Kawai Yasukazu
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Suzuki Hideyoshi
Division Of Hematology Tokyo Metropolitan Komagome Hospital
-
Shishido Hideo
Third Department Of Internal Medicine Dokkyo University School Of Medicine
-
Motoda Kinya
Division Of Epidemiology And Prevention Aichi Cancer Center
-
Sakamaki Hisashi
Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital
-
Miyazaki Yasushi
Department Of Hematology Kinki University School Of Medicine
-
Yano Kunio
県西部浜松医療センター
-
Atsuta Yoshiko
Department Of Hematopoietic Stem Cell Transplantation Data Management Nagoya University Graduate Sch
-
Masuoka Kazuhiro
Department Of Hematology Toranomon Hospital Kajigaya
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Kimura Yoshizo
Department Of Pathology School Of Medicine Kurume University
-
Harada Mine
Division Of Hematology Ehime Prefectural Central Hospital
-
Nishida Tetsuya
Department Of Bacteriology Hiroshima University Graduate School Of Biomedical Sciences
-
Hayashi Shin
Department Of Molecular Cytogenetics Medical Research Institute And School Of Biomedical Science Tok
-
Hara Masamichi
Ehime Prefectural Central Hospital Matsuyama Jpn
-
Hamaguchi M
Division Of Hematology Ehime Prefectural Central Hospital
-
Horiba Masahide
Department Of Allergy National Minamiokayama Hospital
-
Kanemaru Misaki
Department Of Respiratory Medicine Allergy And Rheumatic Diseases Osaka University Graduate School Of Medicine
-
Okamoto Shinichiro
Keio University Hospital
-
Matsuo Keitaro
Division of Cardiology, Nippon Medical School
-
ATSUTA Yoshiko
Department of Hematopoietic Stem Cell Transplantation Data Management and Biostatistics, Graduate School of Medicine, Nagoya University
-
KODERA Yoshihisa
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
関連論文
- ゲノム情報を生かした個別化医療 (特集 固形癌の最新治療--癌治療への新たな取り組み) -- (治療の新たな取り組み 個別化治療)
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- The Authors Reply: Sleep Complaints in Hospitalized Italian Patients with Hematological Malignancies
- Insomnia and Depression during Protective Isolation in Patients with Hematological Disorders
- P-674 大腸癌肝転移切除例のSurgical Marginについての遺伝子学的および組織学的検討
- PP-1137 大腸癌肝転移に対する外科的治療戦略 : Surgical Marginについての遺伝子学的および臨床病理学的検討
- SF-107-4 大腸sm癌のリンパ節転移と遺伝子群のマイクロアレイによる解析(第107回日本外科学会定期学術集会)
- 大腸の増殖形式(PG・NPG)と遺伝子群のマイクロアレイによる解析,悪性度についての検討
- マイクロアレイによる大腸癌の異時性肝転移の高リスク群の抽出
- Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stein cell transplan
- SY-1-2-5 肝細胞癌の進展機構解析による新規分子標的の同定(シンポジウム1-2 消化器癌の発生機序から見た治療戦略-肝胆膵癌,第62回日本消化器外科学会定期学術総会)
- Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stein cell transplan
- PS-095-1 n0乳癌における再発予後予測システムの検討
- SY-6-6 癌遺伝子発現パターンを用いたPaclitaxelの治療効果予知 : 局所進行乳癌に対する術前化療による解析
- 早期大腸癌の発育形態と Ras-signaling Pathway 異常(第105回日本外科学会定期学術集会)
- PS-117-2 散発性大腸癌発癌におけるhMLH1発現低下の意義
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- A-3 インベーダ法によるSNP遺伝子型データの2変量正規混合分布に基づく分類(企画セッション:SNPデータの解析における統計的諸問題)(2003年度統計関連学会連合大会記録(日本統計学会第71回大会))
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- 発がん・増殖 BRCA遺伝子機能とその機能欠損による乳癌発生機序 (乳癌--基礎と臨床の架け橋)
- 図説 最新のゲノムワイド解析技術 (特集 ゲノム研究最前線--疾患ゲノム研究の現状と展望)
- 癌と骨転移のゲノム学 (特集 骨・破壊と再生のゲノム医学)
- 遺伝性乳癌の分子遺伝学--BRCA1を中心に (癌抑制遺伝子--最新トピックス)
- SNPsと有害事象情報 (特集 分子・細胞標的治療--基礎と臨床) -- (基礎)
- がんの遺伝解析 (特集 ポストゲノム時代の医療) -- (ゲノム解析からの病態解明)
- 大腸癌表層部と先進部の発現プロファイル解析
- IS-3-4 乳がん術前化学療法の効果予測システム開発の試み(第108回日本外科会定期学術集会)
- A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
- SF-108-2 大腸癌先進部脱分化に関与する遺伝子群の同定と機能ネットワークの構築(第107回日本外科学会定期学術集会)
- O-109 原発性肺癌切除時の開胸時胸腔内洗浄液における微量肺癌細胞の検出と細胞診の比較(肺癌と分子生物学2, 第47回日本肺癌学会総会)
- DP-009-4 包括的遺伝子発現解析による膵癌リンパ節転移予測マーカーの同定(第108回日本外科学会定期学術集会)
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- P-7 原発性肺癌切除時の開胸時胸腔内洗浄液におけるCEA-mRNAの検出の意義(一般演題(ポスター) トランスレーショナルリサーチ,第48回日本肺癌学会総会)
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- 乳がんのLarge-scale genomic study
- Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
- Allelic Losses of Loci at 3p25.1,8p22,13q12,17p13.3,and 22q13 Correlate with Postoperative Recurrence in Breast Cancer
- Successful cord blood transplantation for mycosis fungoides.
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- HNPCC患者の放射線治療の安全性に関する検討(第105回日本外科学会定期学術集会)
- Multicenter Prospective Study of Interferon-α and Conventional Chemotherapy Versus Bone Marrow Transplantation for Newly Diagnosed Patients With Chronic Myelogenous Leukemia
- Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
- Identifying haplotype block structure using an ancestor-derived model
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells
- Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
- Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
- Frequent Allelic Loss at 6q26-27 in Breast Carcinomas of the Solid-tubular Histologic Type
- Correlation of Allelic Losses and Clinicopathological Factors in Primary Breast Cancers
- Mapping of a Breast Cancer Tumor Suppressor Gene Locus to a 4-cM Interval on Chromosome 18q21
- Clinicopathological Features of Hereditary Breast Cancer
- Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- Identification of Rad51 alteration in patients with bilateral breast cancer
- High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
- Multiplex Mutation Screening of the BRCA1 Gene in 1000 Japanese Breast Cancers
- Infrequent Mutation of the H-Cadherin Gene on Chromosome 16q24 in Human Breast Cancers
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- Bilateral Nonpalpable Breast Carcinomas in a Patient with BRCA2 Germ Line Mutation and Past History of Osteosarcoma
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- 癌抑制遺伝子BRCA1/2の機能およびPARP阻害剤によるBRCA変異陽性乳癌の治療 (特集 癌治療・発癌・老化の鍵を握るDNA修復経路)
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors
- Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells
- Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-α and IL-4 Stimulated Human Lung Fibroblast(Pharmacology)
- Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
- Quality of Life in Adult Patients After Stem Cell Transplantation
- Molecular remission achieved by interferon therapy in a patient with cytogenetically relapsed chronic myelogenous leukemia after syngeneic bone marrow transplantation
- Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlations with platelet recovery, acute graft-versus-host disease and hepatic veno-occlusive disease
- Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
- The Fourth Nagoya International Blood and Marrow Transplantation Symposium : New Horizons in Allogeneic Hematopoietic Cell Transplantation-2001 Revolution
- Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
- Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- Antiproliferative Effect of a Novel Cholecystokinin-B/Gastrin Receptor Antagonist, YM022
- Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors